Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

ERASCA ($ERAS) Releases Q1 2026 Earnings, Stock Rises

None

ERASCA ($ERAS) posted quarterly earnings results for Q1 2026 on Monday, May 11th. The company reported earnings of -$0.11 per share, beating estimates of -$0.21 by $0.10. The company also reported revenue of $0, equaling estimates of $0 by $0.

Stock price change since market close: +3.04%

You can see Quiver Quantitative's $ERAS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

ERASCA Insider Trading Activity

ERAS Insider Trades

ERASCA insiders have traded $ERAS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $ERAS stock by insiders over the last 6 months:

  • EBUN GARNER (Chief Legal Officer) has made 0 purchases and 2 sales selling 200,000 shares for an estimated $1,982,812.
  • SHANNON MORRIS (Chief Medical Officer) sold 20,000 shares for an estimated $300,760

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

ERASCA Hedge Fund Activity

We have seen 96 institutional investors add shares of ERASCA stock to their portfolio, and 69 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

ERASCA Analyst Ratings

Wall Street analysts have issued reports on $ERAS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Guggenheim issued a "Buy" rating on 11/14/2025

To track analyst ratings and price targets for ERASCA, check out Quiver Quantitative's $ERAS forecast page.

ERASCA Price Targets

Multiple analysts have issued price targets for $ERAS recently. We have seen 9 analysts offer price targets for $ERAS in the last 6 months, with a median target of $20.0.

Here are some recent targets:

  • Laura Prendergast from Stifel set a target price of $30.0 on 04/27/2026
  • Anupam Rama from JP Morgan set a target price of $25.0 on 03/18/2026
  • Michael Schmidt from Guggenheim set a target price of $20.0 on 03/16/2026
  • Andres Y. Maldonado from HC Wainwright & Co. set a target price of $20.0 on 03/13/2026
  • Joseph Catanzaro from Mizuho set a target price of $19.0 on 03/13/2026
  • Kelsey Goodwin from Piper Sandler set a target price of $18.0 on 03/13/2026
  • Kaveri Pohlman from Clear Street set a target price of $20.0 on 03/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles